MaaraMet GV 2/0.2

This product is a strip of 10 tablets containing a combination of Metformin, Glimepiride, and Voglibose for managing Type 2 Diabetes Mellitus.

• The description claims the triple-action formula targets multiple aspects of diabetes for better glycemic control.
• The description claims improved insulin sensitivity by helping the body use insulin more effectively.
• The description claims prevention of post-meal sugar spikes through Voglibose slowing carbohydrate digestion.
• The description claims reduced risk of hypoglycemia due to Glimepiride providing steady insulin release.
• The description claims support for weight management in controlling weight gain related to diabetes.
• The description claims lowering HbA1c levels contributing to long-term diabetes management.